European Biotech Acquisition Statistics Share Statistics European Biotech Acquisition has n/a
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding n/a Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 11.96M Failed to Deliver (FTD) Shares 5,235 FTD / Avg. Volume 4.1%
Short Selling Information The latest short interest is 9.58K, so 0% of the outstanding
shares have been sold short.
Short Interest 9.58K Short % of Shares Out n/a Short % of Float 0.07% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is 36.77 and the forward
PE ratio is null.
European Biotech Acquisition's PEG ratio is
-0.99.
PE Ratio 36.77 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 1.06 P/FCF Ratio -250.25 PEG Ratio -0.99
Financial Ratio History Enterprise Valuation European Biotech Acquisition has an Enterprise Value (EV) of 128.52M.
EV / Sales 0 EV / EBITDA -45.61 EV / EBIT -249.65 EV / FCF -249.65
Financial Position The company has a current ratio of 0.45,
with a Debt / Equity ratio of 0.
Current Ratio 0.45 Quick Ratio 0.45 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is 2.89% and Return on Invested Capital is -22.33%.
Return on Equity 2.89% Return on Assets 2.7% Return on Invested Capital -22.33% Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -3.16M Effective Tax Rate -921.86%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so European Biotech Acquisition's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 10.17 200-Day Moving Average n/a Relative Strength Index (RSI) 61.4 Average Volume (20 Days) 127,598
Income Statement
Revenue n/a Gross Profit n/a Operating Income -2.82M Net Income 3.5M EBITDA -2.82M EBIT n/a Earnings Per Share (EPS) 0.27
Full Income Statement Balance Sheet The company has 308.49K in cash and 0 in
debt, giving a net cash position of 308.49K.
Cash & Cash Equivalents 308.49K Total Debt n/a Net Cash n/a Retained Earnings -8.06M Total Assets 129.75M Working Capital -438.93K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -514.79K
and capital expenditures 0, giving a free cash flow of -514.79K.
Operating Cash Flow -514.79K Capital Expenditures n/a Free Cash Flow -514.79K FCF Per Share -0.04
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
